
Medical Device Manufacturer

78 Ms. Hao, aged [years], once hung by a thread due to severe aortic valve stenosis.—— Traditional open-chest surgery carries extremely high risks, while minimally invasive transcatheter aortic valve replacement (TAVR) Moreover, due to the severe calcification of her valve, she faced the potential risk of coronary artery occlusion. This is not an isolated case: among the millions of patients with aortic valve disease worldwide each year, more than 30% miss out on treatment opportunities because of the high difficulty in surgical planning.
10 Month 21 Day, Medical GiantMedtronicAn announcement provided a breakthrough direction: with Ohio DASI Simulations Achieve AI Strategic cooperation, will FDA Approved Intelligent Planning Tools Introduced Nationwide in the U.S. TAVR Project, Let “Customized” Becoming a routine of cardiac surgery.
As the gold-standard technology for treating aortic stenosis,TAVR Although no thoracotomy is required, it conceals three major technical challenges:
1.Coronary Protection: Valve deployment may block blood vessels, leading to myocardial infarction
2.Anchoring Challenge: Non-calcified valves are prone to displacement, leading to surgical failure.
3.Individual Differences: Significant anatomical variations in the aortic root; traditional planning relies on the doctor's experience.
“In the past, preoperative assessment relied on manual measurement of images, which was time-consuming. 40 Minutes may also be possible. 1-2 A millimeter of error can be fatal in heart surgery.” A director of the Cardiology Department at a certain tertiary hospital revealed. DASI The AI The system can compress this process to minute-level, with an error of less than 1 Millimeters.
The core of this cooperation is to DASI The Two Major “Ace Tool” Combined with Medtronic's clinical resources:
1.Digital Twin Modeling: The patient CT Imaging is transformed into a virtual replica of the heart, simulating 10 + Valve Deployment Scenarios: Predicting Coronary Obstruction Risks in Advance
2.Device-independent Suggestions: Regardless of the brand of valve used,AI Can provide the optimal model selection and release angle, reducing 30% The above complications
“We are replacing with data‘Judgment based on experience’。”DASI CEO Teri Sirset Emphasize that the cooperation will enable grassroots hospitals to carry out highly challenging procedures. TAVRMedtronic Structural Heart Leader Jorie Soskin Then add:“This is from‘"One-size-fits-all"’To‘Precise Match’A leap forward, covering the entire journey of patients from diagnosis to recovery.”
This cooperation is not an isolated case: developed by Suzhou enterprises CardioVerse System can 1.8 Minutes to complete preoperative evaluation, Fudan University Zhongshan Hospital uses AI Auxiliary TAVR Let the success rate of the surgery reach 97.7%. Medtronic's layout is even more ambitious —— Its TAVR Product Evolut FX + Has achieved high single-digit growth, this time with叠加 AI Technology, is expected to further consolidate the market position.
For patients, this technological revolution means that the elderly and high-risk individuals no longer have to give up on surgery, and complex cases can receive safer treatment options. As Professor Wei Lai said:“The best medical innovation is to offer each patient a tailored sense of hope.”